Mamento, Hanan S.

HRN: 11-46-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
CEFUROXIME 500MG (TAB)
07/10/2022
07/16/2022
PO
500mg
BID
S/P NSVD Non Institutional Delivery
Waiting Final Action 
09/13/2023
CEFUROXIME 1.5GM (VIAL)
09/13/2023
09/20/2023
IVT
1.5 Gms
Now Then Q 8 Hrs
S/P LTCS
Checking Final Appropriateness 
09/14/2023
CEFUROXIME 500MG (TAB)
09/14/2023
09/20/2023
PO
500mg
BID
S/P CS With BTL
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: